0.00Open0.05Pre Close0 Volume91 Open Interest875.00Strike Price0.00Turnover3147.90%IV14.37%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0048Delta0.0004Gamma15302.00Leverage Ratio-293.8086Theta0.0000Rho73.11Eff Leverage0.0001Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet